<SEC-DOCUMENT>0000064803-19-000024.txt : 20190604
<SEC-HEADER>0000064803-19-000024.hdr.sgml : 20190604
<ACCEPTANCE-DATETIME>20190604065732
ACCESSION NUMBER:		0000064803-19-000024
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190604
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190604
DATE AS OF CHANGE:		20190604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		19875244

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-kxinvestorday.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s59F67D4B16B858408AA9F5880053BC90"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:73%;"></td><td style="width:27%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported):</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 4, 2019</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;"><img src="cvshealtha11.jpg" alt="cvshealtha11.jpg" style="height:18px;width:104px;"></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CVS HEALTH CORPORATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-01011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">05-0494040</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">One CVS Drive, Woonsocket, Rhode Island</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">02895</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant's telephone number, including area code:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(401) 765-1500</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Former name or former address, if changed since last report:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:35%;"></td><td style="width:20%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title of each class</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trading Symbol(s)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock, par value $0.01 per share</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York Stock Exchange</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:97%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.8pt;"><font style="font-family:Wingdings;font-size:9.8pt;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:9.8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="text-align:right;font-size:9.8pt;"><font style="font-family:inherit;font-size:9.8pt;">&#160;&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s3D562FCE716C5DCF89FD3F3776EFD6D9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Section 7 - Regulation FD</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01   Regulation FD Disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with its 2019 Investor Day, on June 4, 2019, CVS Health Corporation&#160;issued a press release that, among other things, discussed its enterprise priorities, reaffirmed its 2019 full year projections and provided initial projections for 2020. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 7.01 by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Section 9 - Financial Statements and Exhibits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01   Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibits</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The exhibit to this Current Report on Form 8-K is as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX TO EXHIBITS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font><a style="text-decoration:underline;color:#0000FF;font-weight:bold;-sec-extract:exhibit;" href="cvs_ex99x1.htm"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">99.1&#160;&#160;&#160;&#160;&#160; Press Release of CVS Health Corporation dated June 4, 2019</font></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:48%;"></td><td style="width:4%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CVS HEALTH CORPORATION</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: June 4, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ Eva C. Boratto</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eva C. Boratto</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cvs_ex99x1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s0DCC5602E30D59A991A7406A8D6D935E"></a></div><div><div style="line-height:120%;text-align:right;padding-left:270px;text-indent:-246px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;99.1</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;"><img src="cvshealtha09.gif" alt="cvshealtha09.gif" style="font-weight:bold;height:64px;width:125px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CVS HEALTH OUTLINES STRATEGY TO ACCELERATE GROWTH</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Significant Expansion of HealthHUBs</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;will Help Drive Differentiated, Consumer-Centric Health Experience; 1,500 Expected to Open by End of 2021</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Strong Execution on Aetna Integration Projected to Drive Approximately $300 - $350 Million of Synergies in 2019; Synergies of Approximately $800 Million Projected in 2020 </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reaffirming 2019 Full Year Guidance; Consolidated Revenues $251.2 to $254.4 Billion, GAAP Operating Income $11.8 to $12.0 Billion, Adjusted Operating Income $15.0 to $15.2 Billion, GAAP diluted EPS $4.90 to $5.05, Adjusted EPS</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">$6.75 to $6.90</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Expect to Deliver $7.00+ Adjusted EPS in 2020, Mid-Single Digit Percent Adjusted EPS Growth in 2021, and Low-Double Digit Percent Adjusted EPS Growth in 2022 and Beyond</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WOONSOCKET, R.I. (June 4, 2019) - The executive team of  CVS Health (NYSE: CVS) will outline a series of transformation initiatives at its 2019 Investor Day today, showing how the company plans to accelerate enterprise growth, simplify a consumer health system that is confusing and inconvenient, and position the company for long-term growth and increased shareholder value. The company also will provide greater insight into near- and long-term earnings potential. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;Our goal is to fundamentally transform the consumer health experience for the millions of Americans we interact with every day, while creating value for our patients, members, partners, and shareholders,&#8221; said Larry J. Merlo, President and Chief Executive Officer, CVS Health. &#8220;We have combined with Aetna to build a powerful and unique business model that will guide our journey to becoming the most consumer-centric health company.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Enterprise Priorities to Accelerate Growth</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS Health is dedicated to putting consumers at the center of its strategy and helping them achieve their best health by strengthening health care locally and making it simpler to use and understand. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The CVS Health management team is focused on:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Growing and differentiating CVS Health&#8217;s businesses</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">with a focus on driving engagement through personalization, winning in high-growth products and services and delivering new and innovative benefit designs and reimbursement models.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expanding HealthHUBs to build on the success of its pilot program in Houston, TX. </font><font style="font-family:inherit;font-size:10pt;">&#32;HealthHUBs are a powerful example of how CVS Health can provide consumers with convenient, personalized and integrated access to local health care. The company will open additional HealthHUBs in Houston, Atlanta, Philadelphia/Southern New Jersey and Tampa this year, and plans to have </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">1,500 total HealthHUBs operating by the end of 2021</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Taking advantage of the unmatched breadth of CVS Health&#8217;s capabilities to introduce new products and services. </font><font style="font-family:inherit;font-size:10pt;">CVS Health will optimize government programs, introduce new risk-based carve-outs, develop programs aimed at complex conditions like chronic kidney disease, and create new analytics products.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Building a robust technology infrastructure designed to support transformational initiatives</font><font style="font-family:inherit;font-size:10pt;">&#32;and protect CVS Health&#8217;s breadth of data. CVS Health will deploy that data across the organization to create a holistic view of the patient, which will offer insights on how to communicate with the patient most effectively, including providing the next best action they can take to improve their health.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Realizing cost savings </font><font style="font-family:inherit;font-size:10pt;">by modernizing enterprise functions and efficiently integrating operations following the Aetna transaction. </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Strong Financial Foundation Will Drive Long-Term Value Creation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS Health CFO Eva Boratto will discuss how a focus on synergies and modernization will drive a more efficient company, and how investments in technology and new products will create long-term value.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;We are continuing to drive significant synergies and cost savings across the entire enterprise as we execute our integration plans,&#8221; Boratto said. &#8220;Going forward, we also have truly exciting opportunities to introduce programs and products that will change the way people think of and address their health.&#8221;   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2019 Guidance</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The company is reaffirming its 2019 full year projections:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Revenues</font><font style="font-family:inherit;font-size:10pt;">: $251.2 to $254.4 billion</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GAAP Operating Income:</font><font style="font-family:inherit;font-size:10pt;">&#32;$11.8 to $12.0 billion</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted Operating Income</font><font style="font-family:inherit;font-size:10pt;">: $15.0 to $15.2 billion</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GAAP diluted EPS</font><font style="font-family:inherit;font-size:10pt;">: $4.90 to $5.05 </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted EPS</font><font style="font-family:inherit;font-size:10pt;">: $6.75 to $6.90</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GAAP Net Cash Provided by Operating Activities: </font><font style="font-family:inherit;font-size:10pt;">$9.8 to $10.3 billion</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Available to Repay Debt</font><font style="font-family:inherit;font-size:10pt;">: $4.2 to $4.6 billion</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Long-Term Earnings Potential</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS Health expects to balance near-term execution with long-term value creation through strategic initiatives and consumer-centric products which are projected to drive Adjusted EPS of at least $7.00 in 2020, mid-single digit percent Adjusted EPS growth in 2021, and low-double digit percent growth in 2022 and beyond. Additional details will be provided in today&#8217;s presentations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Day Webcast</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS Health will host its 2019 Investor Day presentation today beginning at 8 a.m. Eastern Time. The presentation will be available via a live video and audio webcast for all interested parties through the Investor Relations section of the CVS Health website at http://investors.cvshealth.com. The webcast will be archived and available on the website for a one-year period following today&#8217;s Investor Day.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">About CVS Health</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including a rapidly expanding Medicare Advantage offering and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cautionary Statement Regarding Forward-Looking Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include the information in the italicized introductory information and under the headings &#8220;2019 Guidance&#8221; and &#8220;Long-Term Earnings Potential&#8221; and the related endnotes and reconciliations and the information in Mr. Merlo&#8217;s and Ms. Boratto&#8217;s quoted statements. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission filings, </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">including those set forth in the Risk Factors section and under the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You are cautioned not to place undue reliance on CVS Health&#8217;s forward looking statements. These forward-looking statements are and will be based upon management&#8217;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-GAAP Financial Measures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212121;">This press release contains certain non-GAAP financial measures, including adjusted operating income, adjusted earnings per share (Adjusted EPS) and c</font><font style="font-family:inherit;font-size:10pt;">ash available to repay debt</font><font style="font-family:inherit;font-size:10pt;color:#212121;">. In accordance with SEC regulations, you can find the definitions of the Non-GAAP items mentioned, as well as the reconciliations to the most directly comparable GAAP measures, below in this press release.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Contact:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Joe Krocheski</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investor Relations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(860) 273-0896</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Media Contact:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">T.J. Crawford</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">External Affairs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(212) 457-0583</font></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s1A2FE65B671158A484C349F31E402F8C"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-GAAP Financial Measures</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses non-GAAP measures, including adjusted operating income, Adjusted EPS and cash available to repay debt, to analyze underlying business performance and trends. The Company believes that providing these non-GAAP measures enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance. These non-GAAP financial measures are provided as supplemental information to the financial measures presented in this press release that are calculated and presented in accordance with GAAP. Non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. The Company&#8217;s definitions of adjusted operating income, Adjusted EPS and cash available to repay debt may not be comparable to similarly titled measurements reported by other companies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company defines adjusted operating income as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance such as acquisition-related integration costs and store rationalization charges. A reconciliation of projected 2019 operating income to adjusted operating income is provided below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company defines adjusted net income attributable to CVS Health as net income attributable to CVS Health (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance such as acquisition-related integration costs, store rationalization charges, the corresponding tax benefit or expense related to the items excluded from adjusted net income attributable to CVS Health and the corresponding impact to income allocable to participating securities, net of tax, related to the items excluded from net income attributable to CVS Health in determining adjusted net income attributable to CVS Health. GAAP diluted EPS and Adjusted EPS, respectively, are calculated by dividing net income attributable to CVS Health and adjusted net income attributable to CVS Health by the Company&#8217;s weighted average diluted shares outstanding. A reconciliation of projected 2019 net income to projected adjusted net income attributable to CVS Health and a calculation of projected 2019 GAAP diluted EPS and Adjusted EPS is provided below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected Adjusted EPS after 2019 excludes from GAAP diluted EPS the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance, the corresponding tax benefit or expense related to the items excluded from adjusted net income attributable to CVS Health and the corresponding impact to income allocable to participating securities, net of tax, related to the items excluded from net income attributable to CVS Health in determining adjusted net income attributable to CVS Health. The Company is not able to project the amount of any such other items during periods after 2019 at this time and therefore cannot reconcile projected Adjusted EPS after 2019 to projected GAAP diluted EPS. The Company is unable at this time to accurately quantify the significance of any item of unavailable information.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company defines cash available to repay debt as net cash provided by operating activities (GAAP measure) minus cash allocated to fund: (i) net capital expenditures, (ii) shareholder dividends and (iii) additional retained capital needs of its insurance subsidiaries. A reconciliation of projected 2019 net cash provided by operating activities to cash available to repay debt is provided below.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s7e3d8fa55fc14511916d4a49a392046e"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted Operating Income Guidance</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following reconciliation of projected operating income to projected adjusted operating income contains forward-looking information. All forward-looking information involves risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. See also &#8220;Non-GAAP Financial Measures&#8221; above for more information on how we calculate adjusted operating income.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:79%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year&#160;Ending</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December&#160;31,&#160;2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;text-decoration:underline;">In&#160;millions</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Low</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">High</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (GAAP measure)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,765</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-GAAP adjustments:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,520</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,520</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related integration costs </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">550</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">550</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Store rationalization charge</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted operating income </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,970</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">_____________________________________________</sup>&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisition-related integration costs relate to the acquisition of Aetna. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Primarily relates to operating lease right-of-use asset impairment charges in connection with the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="scb6868e80d044177975ac0a62ced3158"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Adjusted Earnings Per Share Guidance</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following reconciliation of projected net income to projected adjusted net income attributable to CVS Health and calculation of projected GAAP diluted EPS and projected Adjusted EPS contain forward-looking information. All forward-looking information involves risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. See also &#8220;Non-GAAP Financial Measures&#8221; above for more information on how we calculate Adjusted EPS.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ending December 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Low</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">High</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;text-decoration:underline;">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Per Common Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Per Common Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income (GAAP measure)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6,420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income attributable to noncontrolling interests (GAAP measure)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Income allocable to participating securities (GAAP measure)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Net income attributable to CVS Health (GAAP measure)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6,405</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">4.90</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6,605</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">5.05</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Non-GAAP adjustments:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Amortization of intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2,520</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1.93</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">2,520</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1.93</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.5pt;">Acquisition-related integration costs</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">550</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">550</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.5pt;">Store rationalization charge</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">135</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">135</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">0.10</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.5pt;">Income tax benefit </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(0.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">(0.60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.5pt;">Income allocable to participating securities, net of tax</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Adjusted net income attributable to CVS Health</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">8,825</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">9,025</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">6.90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">Weighted average diluted shares outstanding</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1,308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;">1,308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">_____________________________________________</sup>&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisition-related integration costs relate to the acquisition of Aetna.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Primarily relates to operating lease right-of-use asset impairment charges in connection with the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the corresponding tax benefit or expense related to the items excluded from adjusted net income attributable to CVS Health and Adjusted EPS above. The nature of each non-GAAP adjustment is evaluated to determine whether a discrete adjustment should be made to the adjusted income tax provision.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the corresponding impact to income allocable to participating securities, net of tax, related to the items above excluded from net income attributable to CVS Health in determining adjusted net income attributable to CVS Health and calculating Adjusted EPS above.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s8c7f141f374f4234aad88793316e9c2f"></a></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Available to Repay Debt</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following reconciliation of projected net cash provided by operating activities to projected cash available to repay debt contains forward-looking information. All forward-looking information involves risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking information for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. See also &#8220;Non-GAAP Financial Measures&#8221; above for more information on how we calculate cash available to repay debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ending </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;text-decoration:underline;">In&#160;millions</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Low</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">High</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities (GAAP measure)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net capital expenditures (additions to property and equipment less sale-leaseback proceeds)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,600</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,300</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shareholder dividends</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional retained capital needs of insurance subsidiaries </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(800</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash available for debt repayment</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">_____________________________________________</sup>&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents a portion of the retained capital required to support the projected insured membership growth in the Health Care Benefits segment.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cvshealtha09.gif
<TEXT>
begin 644 cvshealtha09.gif
M1TE&.#EA1@FP!'   "'Y! $   4 +     !&"; $@@   ,D  ,L  ,\  ,P
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MR($[EX(?*($C^''A5WVL%$P%:<5;+(A3*WB#30>"QW<+")B ;Z-#):A<.NB
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M@[CK*O-:/L'R=2J&'0)@!9%83A(6?GL];%L:&X3%!H*R2Y)\[/XB*]F2SDI
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MQ^]L%+S?(1GX.,&=TH#S-]Z-ACC"7:+P"S@\61=,/^+!K['QB7>DXA;(N!5
M3KF.5\/D'M<(R;EG[S^L''$HGT;,4WY';1680)UX^>!F'@V>T[R2#'^#R,4[
M=!1+'--'__E)=!Z!HD^!Z4MW\_DSI*[T:+8<XT&OJM-GG/11=[WJ(X'Z_*X^
MW*UCD.K-0#O8&9KU(9$]NV;W\==S/?>U?T3LS'G['O!.-K4OP^]VQZG>PS7X
M//!,_6N 3T;B Y_5MO^U\'@X/-86?PS*,UZOD)>IXT4;]R37_=F?OWQ&)*^
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M:)B#D^8V3_I5P#QT!LM[@DUO=,:7U'$JLSSF'_=KII7.=? PW>!:?OHZQ4[
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M;G-^"WB!_U=;7QA\[M>!8\A 9F*&X8*&^Q.$@(@5Q#1I0[B%)-:"0C. !%6
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3J8X-.94O:$=6F95:N97]D   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cvshealtha11.jpg
<TEXT>
begin 644 cvshealtha11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
